Abits
ABTS
FRMO CORP
FRMO
Mawson Infrastructure
MIGI
Ebang International
EBON
BIT Mining
BTCM
US Stock MarketDetailed Quotes
SONN Sonnet BioTherapeutic
- 1.4000
- -0.0900-6.04%
Close Mar 10 16:00 ET
- 1.4700
- +0.0700+5.00%
Post 17:23 ET
4.29MMarket Cap-0.13P/E (TTM)
1.5192High1.4000Low44.51KVolume1.5100Open1.4900Pre Close64.91KTurnover1.48%Turnover RatioLossP/E (Static)3.07MShares18.719252wk High1.06P/B4.21MFloat Cap1.300052wk Low--Dividend TTM3.01MShs Float329609.2800Historical High--Div YieldTTM8.00%Amplitude1.3000Historical Low1.4580Avg Price1Lot Size
Sonnet BioTherapeutic News
Sonnet BioTherapeutics Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors
Express News | Sonnet Biotherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform Is Available for Drug Discovery Partnerships With Potential for Producing Multiple Pipeline Drug Candidates
Sonnet BioTherapeutics Selected for Poster Presentation at the 2025 AACR IO Conference
Sonnet BioTherapeutic | 10-Q: Q1 2025 Earnings Report
Sonnet BioTherapeutics Reports Wider Q1 Net Loss, CFO Transition
Express News | Sonnet Biotherapeutics Appoints Stephen Mcandrew, Ph.d. as Chief Business Officer
Press Release: Sonnet BioTherapeutics Appoints Stephen McAndrew, Ph.D. as Chief Business Officer
Sonnet BioTherapeutics Q1 EPS $(1.56) Misses $(1.39) Estimate
Express News | Sonnet BioTherapeutics CFO Resigns Effective Feb. 21, 2025; Co Names Donald Griffith As Successor
Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Provides Fiscal Year 2025 First Quarter Business and Earnings Update
Sonnet BioTherapeutics Reports Positive Interim Results From Phase 1 SB101 Trial of SON-1010 and Advances Clinical Programs
Sonnet BioTherapeutics Jay Cross Submitted His Resignation as Chief Fincl Officer, Effective Feb 21 >SONN
Press Release: Sonnet BioTherapeutics Provides Fiscal Year 2025 First Quarter Business and Earnings Update
Express News | Sonnet Biotherapeutics Further Expands Global Intellectual Property Portfolio With Issuance of EU Patent for Fhab® Platform Technology
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Sonnet BioTherapeutics Has Been Granted European Patent Number EP3583125 Titled "ALBUMIN BINDING DOMAIN FUSION PROTEINS (FOR THE TREATMENT OF CANCER)".
Express News | Sonnet BioTherapeutics Has Been Granted European Patent Number EP3583125 Titled "ALBUMIN BINDING DOMAIN FUSION PROTEINS (FOR THE TREATMENT OF CANCER)"
Sonnet Expands Phase 1 SB101 Study Of SON-1010, Combining With Trabectedin In Advanced Soft-Tissue Sarcoma; Enrollment Of 18 Patients Expected By H1 2025; Topline Safety Data Due H2 2025; Monotherapy Suggested Clinical Benefit; Potential Phase 2 Study...
Express News | Sonnet Biotherapeutics Holdings Inc - Topline Safety Data Expected in H2 2025
Sonnet BioTherapeutics Expands Phase 1 SB101 Trial to Evaluate Combination of SON-1010 With Trabectedin in Certain Sarcomas
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.